| 000 | 01103 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516153153.0 | ||
| 264 | 0 | _c20140505 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a2164-554X | ||
| 024 | 7 |
_a10.4161/hv.24689 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFindlow, Jamie | |
| 245 | 0 | 0 |
_aMeningococcal group B vaccines. _h[electronic resource] |
| 260 |
_bHuman vaccines & immunotherapeutics _cJun 2013 |
||
| 300 |
_a1387-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization Schedule |
| 650 | 0 | 4 |
_aMeningococcal Infections _xepidemiology |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aNeisseria meningitidis, Serogroup B _ximmunology |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 650 | 0 | 4 |
_aVaccines, Conjugate _xadministration & dosage |
| 773 | 0 |
_tHuman vaccines & immunotherapeutics _gvol. 9 _gno. 6 _gp. 1387-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/hv.24689 _zAvailable from publisher's website |
| 999 |
_c22804610 _d22804610 |
||